As a knowledge platform, eu.reca continuously aims to establish and maintain connections between, amongst others, health care professionals, business people and start-ups in order to stimulate innovation in the respiratory field. To fuel discussions and trigger progress, we have now launched a new medium to share interesting point of views on respiratory-related topics with our community.
The current Corona crisis and the damage caused by Covid-19 to the lungs is a new illustration of the vulnerability of this vital organ. Focusing exclusively on all aspects related to lunghealth, the non-profit organisation eu.reca works with experts that are directly connected to the frontline healthcare providers who manage the consequences of the crisis. We have asked them to share some reflections about the crisis and its impact on the themes eu.reca works on, such as clinical trials and product development in respiratory. In a number of short contributions our experts discuss the expected impact of the crisis on our future way of working, but also on the opportunities that might arise. We hope you will enjoy these “Points of View”. ”
PART 1 – Covid-19 Where do we go?
Prof. dr. Marc Decramer tackles the most important question: “What have we learned from the present pandemic and how will we master these crises better in the future?”